Connect with us


CBD Treatment Case Traumatic Brain Injuries TBI



Occasionally, medical science turns the page and manages to move forward in a manner that can benefit us all. One such example is the recently growing research into a condition now known as TBI, or traumatic brain injury.

This is different from a more basic head injury in that it results in structural changes inside the brain that can affect a number of different processes and experiences over the course of the individual’s remaining lifespan. It is also far more likely to result in devastating problems or even fatality.

Understanding TBI

The critical factor in defining traumatic brain injury is inflammation inside the brain. This inflammatory condition for cortical tissue can lead to chemical damage that can cause permanent changes to mood, personality, and cognitive capacities and abilities.

It is believed that as many as 2 million people in the United States alone sustained some form of traumatic brain injury. The typical culprits are contact sports such as football or MMA, car accidents, or simple falls.

Overwhelmingly, the cause is some sort of blunt force trauma to the head or neck. This primary injury can cause the bursting of blood vessels and the potential for physical reordering of the tissue itself.

Generally speaking, it is the secondary injuries that stem from this initial trauma that often result in the more serious medical conditions. As the brain attempts to reassemble its circumstances following the initial trauma, we often see chemical changes occur in the hours and days that follow the initial blunt force shock to the head or neck. In fact, this period of hours or days immediately following the initial trauma is when CBD can possibly be of powerful positive consequence.

As you know, the brain is made up of individual cells, called neurons and glia. These second forms can be further broken down into several classes, of which one of the most important are the microglia. These cells are essentially the functional units of the immune system inside the brain. Importantly, typical immune system cells are not allowed in the brain – they can’t cross over the so-called blood-brain barrier.

It is these microglia that function in their stead.

Understanding the Blood Brain Barrier

Anywhere in the body, when there is damage or an attack from some form of pathogen, a warning signal is sent out, and the immune system responds, riding to the rescue. However, inside the environment of the brain, there is a different system in place. The brain is actually cut off from the rest of the body in a manner that might be seen as somewhat similar to the pilot cockpit of a passenger plane. When someone riding back in coach or even first class has a problem, there are systems on the plane to deal with them. But when someone in the cockpit has a problem, there are very different systems in place to deal with that.

This is something like the difference between the brain and the rest of the body. And the cockpit door is what’s known as the blood brain barrier.

And this is very important: much of what flows through the rest of our body would be toxic to brain tissue. So it remains behind its barrier, protected from the toxic reality of the rest of the body.


A great deal of research has been conducted recently by those in the medical profession, and some of this has actually been focused on the therapeutic effects of cannabidiol and other cannabinoids for a variety of different health conditions. In addition, we also seen a great deal of research of late about TBI.

At the intersection of these two research agendas, some pretty interesting conclusions have begun to emerge. Most importantly, some research suggests, along with a variety of different anecdotal claims, that cannabis and cannabidiol may significantly improve the long run consequences of a traumatic brain injury when applied, administered, or consumed in the hours and days immediately following the initial injury.

As discussed above, the key here is about understanding the role that inflammation plays in the reorganization of brain tissue and brain chemistry in the short period that follows a traumatic injury to the brain.

As we have discussed, CBD has shown immense efficacy in cutting off the body’s response of building an inflammatory regime in an active process to respond to some form of trauma, injury, or invasion by an outside attacker. In addition, CBD also functions to provide other powerful positives in such a situation, including its antioxidant and palliative effects.

In other words, it would appear as though CBD may be an emerging leader in the process of developing weapons to battle back against cases of traumatic brain injury.

Continue Reading


CannTrust Holdings Inc (NYSE:CTST) Penetrates Into The United States After Investing $20 Million



CannTrust Holdings Inc (NYSE:CTST), a Canadian company that produces and sells medical and recreational marijuana has announced the expansion of its business into the United States.

The Canadian firm revealed that it signed a Letter of Intent through which it will start working with Elk Grove Farming Company, LLC to access more than 3,000 hemp production acres in California. The two companies struck a joint partnership that will allow CannTrust to secure a footing in the California market which is one of the biggest cannabis markets in the U.S.

“This agreement represents another bold move for CannTrust. Our U.S. operation is expected to deliver a significant increase in low-cost production capacity,” stated CannTrust CEO Peter Aceto.

CannTrust is financially ready to tap into the U.S market

The CannTrust CEO also noted that the company will take advantage of its experience in the formulation of standardized CBD products as part of its strategy to enter the U.S market. Mr. Aceto also revealed that his company’s successful equity offering provided enough financial muscle to fuel its ambitious expansion plans.

CannTrust aims to be among the leading and trusted suppliers of high-quality, standardized CBD formulations derived from hemp. The company believes that there will be an increasing demand for high-grade CBD formulations from international retailers. It therefore makes sense to invest in processes that will add value to the end product such as genetic studies and expert growing practices to achieve the highest safety and quality standards.

Elk Grove and CannTrust will each have 50% ownership in their joint operations. Elk Grove is an ideal partner for the endeavor because it has years of farming experience in a variety of products. Its focus includes products designed for crop protection, supply, and input. Its operations are distributed across California, which means that the groundwork has already been laid for the partnership. It will thus be easier for the CannTrust to penetrate into the California market.

Elk Grove executive Morgan Houchin stated that his company was excited about the partnership with CannTrust. He added that his firm’s experience in farming operations will be a great combination with CannTrust’s experience in creating class-leading formulations.

Continue Reading


Rocky Mountain High Brands Inc (OTCMKTS:RMHB) Strikes Broker Deal With Carlin Group



Lifestyle brand management firm Rocky Mountain High Brands Inc (OTCMKTS:RMHB) announced on Wednesday that it secured a broker deal with Carlin Group for its products in the retail space.

The broker agreement will allow Carlin to represent RMHB’s CBD-infused drinks through the HEMPd brand. It will also represent beverages infused with Hempseed extract under RMHB brands. The deal will also cover CBD-infused wellness products such as lotions, water-soluble solutions, capsules, gummies and tinctures as part of the HEMPd brand. Spirit Water will also be covered under the agreement.

The RMHB-Carlin broker deal covers multiple states. They include Missouri, Nebraska, Texas, South Dakota, North Dakota, Minnesota, Wisconsin, Illinois, Pennsylvania, Tennessee, Kentucky, Ohio, Indiana, and Michigan.

“We are very excited about the opportunity to have our entire product line represented by Carlin Group,” stated RMHB CEO Michael Welch.

The Carlin broker deal will boost RMHB’s exposure

Welch noted that the broker deal will strategically allow RMHB to leverage optimal exposure to mass marketers, grocery store chains, convenient stores, major retailers and other types of outlets. The company would not have managed to reach such a wide range of outlets cost-effectively without a broker deal.

The RMHB CEO also added that his company and Carlin will maintain a close collaboration so that they can facilitate retail availability of RMHB products. Welch also revealed that RMHB reviewed numerous other retail introduction options. This was before settling on Carlin which the company believes is the best-suited brand to rapidly get its products onto retail shelves.

Carlin Group’s Managing Director Albert Vergilio noted in a statement that his company was excited to host RMHB and the CBD-based products that are part of its HEMPd brand in Carlin’s new CBD division. He also added that it is part of investing in the future of CBD considering the fast-tracked popularity of CBD products, and the regulations that govern them.

Carlin’s sales team will undergo some training to get them acquainted with RMBH’s products. The sales team will then hold meetings with corporate customers as part of the retail rollout of the products. Sales that will be part of the broker deal are expected to kick off in Q3.

Continue Reading


Wildflower Brands Inc (OTCMKTS:WLDFF) Establishes Footprint Across The US With PO For Hemp CBD Products From Dillard’s Department Stores And Eyes Markets In Texas And Florida



Wildflower Brands Inc (OTCMKTS:WLDFF) has announced establishing a nationwide presence with a PO from Dillard’s Department store. The company has fulfilled the PO received from Dillard.

Hemp CBD products in 292 locations

Dillard’s department store will showcase the premium hemp CBD products of Wildflower in its 292 locations across the US. With its best practices and transparency, Wildflower is eyeing the key markets in Texas and Florida. The company will educate the customers in these regions about salable products. Wildflower has received subsequent orders from Dillard’s and is fulfilling the requirements.

Chief Executive Officer of Wildflower, William Maclean said the supply of CBD infused products to Dillard’s Department stores doubles the existing retail locations in the nation. The company aims to capitalize on its brand to become a household name. It will improve loyalty building because of the reputation and respect of Dillard’s as a retailer. Wildflower aims to provide health and wellness benefits of its CBD infused products to the customers in the US through Dillard’s.

Signs a deal with Highmark Interactive

Wildflower has signed a deal to use EQ – Brain Tracking, mobile software of Highmark Interactive, in the clinical research to study the functional neurological and cognitive effects of CBD. The company aims to get meaningful results and data that help to understand the functional and cognitive neurological properties of the cannabinoids.

William said the company would collect testimonials from the customers on its products that provide the health and wellness needs using plant-based solutions. The company will strive to improve the products, and the research helps it to reach that goal and growth with continued investments.

Acquires City Cannabis Corp

Wildflower has signed an LOI on April 3, 2019, to take over City Cannabis Corp. The company will issue its 60 million common shares for the takeover. The companies will complete the acquisition on receiving advice from corporate, tax, and securities law departments.

The cannabis retailer City Cannabis holds two licenses in the City of Vancouver to market cannabis. It is generating profits through operating dispensaries in Vancouver. The acquisition helps Wildflower to expand retail footprint using the expertise of City Cannabis.

Continue Reading

Trending Stories